Cita APA

Tan, M., Mosaoa, R., Graham, G. T., Kasprzyk-Pawelec, A., Gadre, S., Parasido, E., . . . Avantaggiati, M. L. (2020). Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH. Cell Death Differ.

Citación estilo Chicago

Tan, Mingjun, et al. "Inhibition of the Mitochondrial Citrate Carrier, Slc25a1, Reverts Steatosis, Glucose Intolerance, and Inflammation in Preclinical Models of NAFLD/NASH." Cell Death Differ 2020.

Cita MLA

Tan, Mingjun, et al. "Inhibition of the Mitochondrial Citrate Carrier, Slc25a1, Reverts Steatosis, Glucose Intolerance, and Inflammation in Preclinical Models of NAFLD/NASH." Cell Death Differ 2020.